AmerisourceBergen Corp. (ABC) CFO Sells $1,083,440.00 in Stock
AmerisourceBergen Corp. (NYSE:ABC) CFO Tim G. Guttman sold 11,600 shares of the business’s stock in a transaction dated Wednesday, January 3rd. The stock was sold at an average price of $93.40, for a total transaction of $1,083,440.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Shares of AmerisourceBergen Corp. (NYSE ABC) traded down $0.21 during mid-day trading on Thursday, hitting $94.18. The stock had a trading volume of 1,781,646 shares, compared to its average volume of 1,318,300. AmerisourceBergen Corp. has a 1-year low of $71.90 and a 1-year high of $97.85. The stock has a market capitalization of $20,540.00, a price-to-earnings ratio of 58.14, a price-to-earnings-growth ratio of 1.63 and a beta of 0.99. The company has a debt-to-equity ratio of 1.83, a current ratio of 0.91 and a quick ratio of 0.48.
AmerisourceBergen (NYSE:ABC) last issued its earnings results on Thursday, November 2nd. The company reported $1.33 EPS for the quarter, beating the Zacks’ consensus estimate of $1.32 by $0.01. The firm had revenue of $39.12 billion for the quarter, compared to analyst estimates of $40.10 billion. AmerisourceBergen had a return on equity of 56.29% and a net margin of 0.27%. AmerisourceBergen’s revenue for the quarter was up 4.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.30 earnings per share. equities analysts expect that AmerisourceBergen Corp. will post 6.08 earnings per share for the current year.
ABC has been the subject of a number of recent research reports. Needham & Company LLC set a $93.00 target price on shares of AmerisourceBergen and gave the stock a “buy” rating in a report on Tuesday, October 24th. Robert W. Baird reiterated a “buy” rating and issued a $96.00 target price on shares of AmerisourceBergen in a report on Monday, November 6th. ValuEngine upgraded shares of AmerisourceBergen from a “hold” rating to a “buy” rating in a report on Tuesday, October 31st. Deutsche Bank initiated coverage on shares of AmerisourceBergen in a report on Monday, December 4th. They issued a “buy” rating and a $97.00 target price for the company. Finally, Cowen set a $107.00 target price on shares of AmerisourceBergen and gave the stock a “buy” rating in a report on Tuesday, December 12th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating, ten have given a buy rating and one has issued a strong buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $95.26.
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.